Search results
Undisputed Heavyweight Champion Boxer Oleksandr Usyk Joins Dwayne Johson In ‘The Smashing Machine’...
Deadline Hollywood· 2 days agoEXCLUSIVE: Following his massive victory against Tyson Fury to become the newly crowned Undisputed ...
Heavyweight Boxing Champion Oleksandr Usyk Joins A24’s ‘The Smashing Machine’
The Wrap via Yahoo News· 2 days agoThe biopic on the life of fighter Mark Kerr stars Dwayne Johnson and Emily Blunt The post...
When Did the Smashing Machine Mark Kerr Compete in His Last MMA Fight?
COMINGSOON.net via Yahoo News· 3 days agoMark Kerr is a retired American wrestler and mixed martial artist known for his stint in the...
The Rock 'The Smashing Machine' movie: What to know about Dwayne Johnson film about former MMA star...
Sporting News· 5 days agoGet ready to see Dwayne "The Rock" Johnson like never before. Johnson has left his mark across a...
Dwayne Johnson Transforms In First Pic From A24's The Smashing Machine
Bleeding Cool· 5 days agoA24 has released the first photo of Dwayne Johnson as MMA fighter Mark Kerr in the new film The...
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab...
FOX 4 Kansas City· 3 days agoPhase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium...
Antengene To Present One Oral and Four Abstracts at ASCO 2024
The Pilot News· 3 days agoAntengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoPreliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically unresponsive to pembrolizumab, such as non-small cell lung cancer (NSCLC) with oncogenic
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoCHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective depletion of peripheral CCR8+ regulatory T cells (Tregs) was observed and depletion was maintained